ClinicalTrials.gg
Sign In

BiologicalDrug

MART-1 Antigen clinical trials

studies test it
14
open now
0
in phase 3
0
first study started
1997

How studies write it

Studies that test it under each name

Name

MART-1 antigen
13

Studies by the year they started

14 studies that test it; most in 1999 (3)

Studies that test MART-1 Antigen, by start year
YearStudies
19971
19993
20003
20012
20021
20032
20071
20111

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
11

What it is tested for

Each study’s main condition, where its own words name it.

Melanoma
13
Uveal Melanoma
1

Who runs them

Industry 1 · Other 13

National Cancer Institute (NCI) (6) · University of Southern California (5) · Mayo Clinic (1) · Eastern Cooperative Oncology Group (1) · Genzyme, a Sanofi Company (1)

Often tested with

Tested in the same studies.

GP-100 antigen (12) · Interleukin-2 (2) · Interleukin-12 (2) · Tyrosinase Peptide (2) · Incomplete Freund's adjuvant (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Sargramostim (1) · gp100:209-217(210M) Peptide Vaccine (1)

Studies

Open first, then newest update. How each study uses MART-1 Antigen is read from its arms, and is right about nine times in ten.

Testing it · 14

Given in every arm · 6 — MART-1 Antigen is usual care beside what is tested
As the comparator · 1 — what is tested is compared with MART-1 Antigen